Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Neues zur nichtalkoholischen Steatohepatitis.
New aspects of nonalcoholic steatohepatitis.
Internist 60, 128-132 (2019)
During the past 10 years nonalcoholic fatty liver disease (NAFLD) has moved more and more into the focus of attention of clinical research. The term NAFLD comprises the simple nonalcoholic steatosis or fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). As the incidence of NAFLD has dramatically increased, it is expected that during the coming years NASH in particular will become the main reason for liver transplantation in industrialized countries. In addition, it has become evident that scirrhotic liver fibrosis can develop directly from NAFL without going through the stage of NASH. Finally, there is accumulating evidence that both NAFL and NASH are strongly associated with an increased risk of type2 diabetes and cardiovascular diseases and on the other hand that NAFL and NASH are complications of diabetes. This article addresses the current knowledge about the prevalence, diagnosis, risk prediction and treatment of NAFLD.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
0.427
0.162
1
1
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Schlagwörter
Nonalcoholic Fatty Liver Disease ; Diabetes Mellitus ; Type2 ; Cardiovascular Diseases ; Liver Cirrhosis ; Inflammation; Fatty Liver; Progression
Sprache
deutsch
Veröffentlichungsjahr
2019
HGF-Berichtsjahr
2019
ISSN (print) / ISBN
0020-9554
e-ISSN
1432-1289
Zeitschrift
Internist, Der
Quellenangaben
Band: 60,
Heft: 2,
Seiten: 128-132
Verlag
Springer
Verlagsort
Berlin ; Heidelberg
Begutachtungsstatus
Peer reviewed
POF Topic(s)
90000 - German Center for Diabetes Research
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502400-001
WOS ID
WOS:000458169100004
Scopus ID
85060145453
PubMed ID
30645665
Erfassungsdatum
2019-03-12